Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple Clinical Trial

Official title: Prospective Placebo-controlled Study of Synochi Scar Spray

Status Not yet recruiting

Clinical Trial Summary

Randomized, double-blind, placebo controlled, prospective, split-scar study of severe burn victims with autologous skin transplants. 9 months intervention time and 3 months follow-up, photographic scar documentation, self-and observer questionnaires throughout

Clinical Trial Description

Interventional, comparative, prospective, evaluator blinded, randomized, placebo- controlled, split-scar model longitudinal study including 28-31 healthy study participants (See Section 6 Statistical Considerations) with both the original burn scar area that is the skin graft recipient area and the skin graft donor site. ;

Related Conditions & MeSH terms

• Burns Multiple

• NCT number: NCT05138107
• Study type: Interventional
• Source: Synochi, LLC
• Contact: Justin Gillenwater, MD
• Phone: (323)409-7750
• Email: Justin.Gillenwater@med.usc.edu
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2022
• Completion date: July 17, 2025